Compounds > clofarabine
Page last updated: 2024-09-03

clofarabine and lestaurtinib

clofarabine has been researched along with lestaurtinib in 2 studies

Compound Research Comparison

Studies
(clofarabine)		Trials
(clofarabine)		Recent Studies (post-2010)
(clofarabine)		Studies
(lestaurtinib)		Trials
(lestaurtinib)		Recent Studies (post-2010) (lestaurtinib)
4241012801241263

Protein Interaction Comparison

ProteinTaxonomyclofarabine (IC50)lestaurtinib (IC50)
Tyrosine-protein kinase JAK2Homo sapiens (human)0.0009
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)0.031
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0039
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.012

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tallman, M1
Gore, SD1

Other Studies

2 other study(ies) available for clofarabine and lestaurtinib

ArticleYear
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
    Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11

    Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin

2008
New agents for the treatment of AML recent study findings.
    Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11

    Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Carbazoles; Clofarabine; Decitabine; Enzyme Inhibitors; Furans; Humans; Hydrazines; Immunotherapy; Lenalidomide; Leukemia, Myeloid, Acute; Quinolones; Staurosporine; Sulfonamides; Thalidomide

2008